As one of the first in the world to produce clinical-grade human pluripotent cells, we have a wealth of experience with a range of reprogramming technologies, expansion strategies and all aspects of quality control testing.
We are here to support the end-to-end development of your GMP iPSC lines:
- Sourcing of the starting donor material
- Derivation of iPSC
- Generation and characterisation of Seed Lot/ Master Cell/ Working Cell Banks
- Quality control assay development and qualification
- Support with long-term cryostorage
and provide regulatory and ethical guidance and support throughout the whole process.